Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
16.94
+0.86 (5.35%)
At close: May 8, 2026, 4:00 PM EDT
16.73
-0.21 (-1.22%)
After-hours: May 8, 2026, 7:43 PM EDT
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $917.91 million as of May 8, 2026. Its market cap has increased by 910.86% in one year.
Market Cap
917.91M
Enterprise Value
465.70M
1-Year Change
910.86%
Ranking
Category
Stock Price
$16.94
Market Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $917.91M, a decrease of -29.34%. That is a compound annual growth rate of -6.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 917.91M | 81.24% |
| Dec 31, 2025 | 506.46M | 266.35% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 895.03M |
| Absci | 893.82M |
| ARS Pharmaceuticals | 893.68M |
| Janux Therapeutics | 886.38M |
| Design Therapeutics | 880.64M |
| Theravance Biopharma | 876.78M |
| Bright Minds Biosciences | 874.60M |
| CytomX Therapeutics | 870.78M |